A detailed history of United Community Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, United Community Bank holds 6,098 shares of GILD stock, worth $596,994. This represents 0.2% of its overall portfolio holdings.

Number of Shares
6,098
Previous 5,953 2.44%
Holding current value
$596,994
Previous $408 Million 25.17%
% of portfolio
0.2%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$66.59 - $83.99 $9,655 - $12,178
145 Added 2.44%
6,098 $511 Million
Q2 2024

Aug 02, 2024

BUY
$63.15 - $72.88 $199,301 - $230,009
3,156 Added 112.84%
5,953 $408 Million
Q1 2024

May 03, 2024

BUY
$71.58 - $87.29 $2,720 - $3,317
38 Added 1.38%
2,797 $205 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $8,059 - $9,139
-110 Reduced 3.83%
2,759 $224 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $212,133 - $231,442
2,869 New
2,869 $215 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $123B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track United Community Bank Portfolio

Follow United Community Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Community Bank with notifications on news.